Evozyne (Series B)

Funding Details
Awarder
Inbox
Date Award
September 29, 2023
Vertical
Biotechnology
Funding URL
View Funding Page
Funding Amount:
$81,000,000

Company Info
Company Description
Evozyne combines evolution and deep learning technology to create highly functional novel proteins - Natural Machines - to solve longstanding challenges in therapeutics and sustainability. By amplifying a protein's function based on the rules of nature, we address complex, high-impact problems.
Market
Therapeutics and Sustainability
Location
Chicago, IL, USA
Coinvestors
Fidelity Management & Research Company, NVentures, OrbiMed US, Paragon Biosciences, Valor Equity Partners

Links